Assessment of drug utilization patterns and associated survival outcomes in recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC): Insights from a resource-constrained set-up.

Patel V, Khadela A, Kothari R, Shah VB

Open source

DOI
10.1177/10781552261478232
Published
2026 Aug 14
Container
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1177/10781552261478232,
  title = {Assessment of drug utilization patterns and associated survival outcomes in recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC): Insights from a resource-constrained set-up.},
  author = {Patel V and Khadela A and Kothari R and Shah VB},
  year = {2026},
  journal = {Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners},
  doi = {10.1177/10781552261478232},
  url = {https://doi.org/10.1177/10781552261478232}
}

RIS

TY  - JOUR
TI  - Assessment of drug utilization patterns and associated survival outcomes in recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC): Insights from a resource-constrained set-up.
AU  - Patel V
AU  - Khadela A
AU  - Kothari R
AU  - Shah VB
PY  - 2026
JO  - Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
DO  - 10.1177/10781552261478232
UR  - https://doi.org/10.1177/10781552261478232
ER  - 

APA

V, P., A, K., R, K., & VB, S. (2026). Assessment of drug utilization patterns and associated survival outcomes in recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC): Insights from a resource-constrained set-up.. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners. https://doi.org/10.1177/10781552261478232

Source records